Ahn TB, Kim SY, Kim JY, Park SS, Lee DS, Min HJ, Kim YK, Kim SE, Kim JM, Kim HJ, Cho J, Jeon BS (2008) Alpha-Synuclein gene duplication is present in sporadic Parkinson disease. Neurology 70:43–49. https://doi.org/10.1212/01.wnl.0000271080.53272.c7
Article
CAS
PubMed
Google Scholar
Allen NJ, Eroglu C (2017) Cell biology of astrocyte-synapse interactions. Neuron 96:697–708. https://doi.org/10.1016/j.neuron.2017.09.056
Article
CAS
PubMed
PubMed Central
Google Scholar
Almutairi MM, Gong C, Xu YG, Chang Y, Shi H (2016) Factors controlling permeability of the blood-brain barrier. Cell Mol Life Sci 73:57–77. https://doi.org/10.1007/s00018-015-2050-8
Article
CAS
PubMed
Google Scholar
Alvarez JI, Katayama T, Prat A (2013) Glial influence on the blood brain barrier. Glia 61:1939–1958. https://doi.org/10.1002/glia.22575
Article
PubMed
PubMed Central
Google Scholar
Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15:961–973. https://doi.org/10.1016/0896-6273(95)90186-8
Article
CAS
PubMed
Google Scholar
Banks WA, Kovac A, Majerova P, Bullock KM, Shi M, Zhang J (2017) Tau proteins cross the blood-brain barrier. J Alzheimers Dis 55:411–419. https://doi.org/10.3233/jad-160542
Article
CAS
PubMed
Google Scholar
Barbour R, Kling K, Anderson JP, Banducci K, Cole T, Diep L, Fox M, Goldstein JM, Soriano F, Seubert P, Chilcote TJ (2008) Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis 5:55–59. https://doi.org/10.1159/000112832
Article
CAS
PubMed
Google Scholar
Blasberg RG, Fenstermacher JD, Patlak CS (1983) Transport of alpha-aminoisobutyric acid across brain capillary and cellular membranes. J Cereb Blood Flow Metab 3:8–32. https://doi.org/10.1038/jcbfm.1983.2
Article
CAS
PubMed
Google Scholar
Booth HDE, Hirst WD, Wade-Martins R (2017) The role of astrocyte dysfunction in Parkinson's disease pathogenesis. Trends Neurosci 40:358–370. https://doi.org/10.1016/j.tins.2017.04.001
Article
CAS
PubMed
PubMed Central
Google Scholar
Braak H, Del Tredici K (2017) Neuropathological staging of brain pathology in sporadic Parkinson's disease: separating the wheat from the chaff. J Park Dis 7:S73–s87. https://doi.org/10.3233/jpd-179001
Article
Google Scholar
Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197–211. https://doi.org/10.1016/s0197-4580(02)00065-9
Article
PubMed
Google Scholar
Braak H, Sastre M, Del Tredici K (2007) Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease. Acta Neuropathol 114:231–241. https://doi.org/10.1007/s00401-007-0244-3
Article
CAS
PubMed
Google Scholar
Bridi JC, Hirth F (2018) Mechanisms of alpha-Synuclein induced Synaptopathy in Parkinson's disease. Front Neurosci 12:80. https://doi.org/10.3389/fnins.2018.00080
Article
PubMed
PubMed Central
Google Scholar
Butchbach ME, Tian G, Guo H, Lin CL (2004) Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function. J Biol Chem 279:34388–34396. https://doi.org/10.1074/jbc.M403938200
Article
CAS
PubMed
Google Scholar
Chavarria C, Rodriguez-Bottero S, Quijano C, Cassina P, Souza JM (2018) Impact of monomeric, oligomeric and fibrillar alpha-synuclein on astrocyte reactivity and toxicity to neurons. Biochem J 475:3153–3169. https://doi.org/10.1042/BCJ20180297
Article
CAS
PubMed
Google Scholar
Cholerton BA, Zabetian CP, Quinn JF, Chung KA, Peterson A, Espay AJ, Revilla FJ, Devoto J, Watson GS, Hu SC, Edwards KL, Montine TJ, Leverenz JB (2013) Pacific Northwest Udall center of excellence clinical consortium: study design and baseline cohort characteristics. J Park Dis 3:205–214. https://doi.org/10.3233/jpd-130189
Article
Google Scholar
Chung EK, Chen LW, Chan YS, Yung KK (2008) Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats. J Comp Neurol 511:421–437. https://doi.org/10.1002/cne.21852
Article
CAS
PubMed
Google Scholar
Chung WS, Allen NJ, Eroglu C (2015) Astrocytes control synapse formation, function, and elimination. Cold Spring Harb Perspect Biol 7:a020370. https://doi.org/10.1101/cshperspect.a020370
Article
CAS
PubMed
PubMed Central
Google Scholar
Comi C, Magistrelli L, Oggioni GD, Carecchio M, Fleetwood T, Cantello R, Mancini F, Antonini A (2014) Peripheral nervous system involvement in Parkinson's disease: evidence and controversies. Parkinsonism Relat Disord 20:1329–1334. https://doi.org/10.1016/j.parkreldis.2014.10.010
Article
CAS
PubMed
Google Scholar
Cui Y, Yang Y, Ni Z, Dong Y, Cai G, Foncelle A, Ma S, Sang K, Tang S, Li Y, Shen Y, Berry H, Wu S, Hu H (2018) Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression. Nature 554:323–327. https://doi.org/10.1038/nature25752
Article
CAS
PubMed
Google Scholar
da Fonseca AC, Matias D, Garcia C, Amaral R, Geraldo LH, Freitas C, Lima FR (2014) The impact of microglial activation on blood-brain barrier in brain diseases. Front Cell Neurosci 8:362. https://doi.org/10.3389/fncel.2014.00362
Article
CAS
PubMed
PubMed Central
Google Scholar
Derkinderen P, Rouaud T, Lebouvier T, Bruley des Varannes S, Neunlist M, De Giorgio R (2011) Parkinson disease: the enteric nervous system spills its guts. Neurology 77:1761–1767. https://doi.org/10.1212/WNL.0b013e318236ef60
Article
CAS
PubMed
Google Scholar
Desai BS, Monahan AJ, Carvey PM, Hendey B (2007) Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy. Cell Transplant 16:285–299. https://doi.org/10.3727/000000007783464731
Article
PubMed
Google Scholar
Dunn KW, Kamocka MM, McDonald JH (2011) A practical guide to evaluating colocalization in biological microscopy. Am J Physiol Cell Physiol 300:C723–C742. https://doi.org/10.1152/ajpcell.00462.2010
Article
CAS
PubMed
PubMed Central
Google Scholar
El-Agnaf OM, Salem SA, Paleologou KE, Curran MD, Gibson MJ, Court JA, Schlossmacher MG, Allsop D (2006) Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. FASEB J 20:419–425. https://doi.org/10.1096/fj.03-1449com
Article
CAS
PubMed
Google Scholar
Fazio P, Svenningsson P, Cselenyi Z, Halldin C, Farde L, Varrone A (2018) Nigrostriatal dopamine transporter availability in early Parkinson's disease. Mov Disord 33:592–599. https://doi.org/10.1002/mds.27316
Article
CAS
PubMed
Google Scholar
Filippi L, Manni C, Pierantozzi M, Brusa L, Danieli R, Stanzione P, Schillaci O (2005) 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms. Nucl Med Commun 26:421–426. https://doi.org/10.1097/00006231-200505000-00005
Article
CAS
PubMed
Google Scholar
Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34:521–533
Article
CAS
Google Scholar
Gray MT, Woulfe JM (2015) Striatal blood-brain barrier permeability in Parkinson's disease. J Cereb Blood Flow Metab 35:747–750. https://doi.org/10.1038/jcbfm.2015.32
Article
CAS
PubMed
PubMed Central
Google Scholar
Gu XL, Long CX, Sun L, Xie C, Lin X, Cai H (2010) Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice. Mol Brain 3:12. https://doi.org/10.1186/1756-6606-3-12
Article
CAS
PubMed
PubMed Central
Google Scholar
Guo H, Lai L, Butchbach ME, Stockinger MP, Shan X, Bishop GA, Lin CL (2003) Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Hum Mol Genet 12:2519–2532. https://doi.org/10.1093/hmg/ddg267
Article
CAS
PubMed
Google Scholar
Gustafsson G, Lindstrom V, Rostami J, Nordstrom E, Lannfelt L, Bergstrom J, Ingelsson M, Erlandsson A (2017) Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes. J Neuroinflammation 14:241. https://doi.org/10.1186/s12974-017-1018-z
Article
CAS
PubMed
PubMed Central
Google Scholar
Hoekstra JG, Cook TJ, Stewart T, Mattison H, Dreisbach MT, Hoffer ZS, Zhang J (2015) Astrocytic dynamin-like protein 1 regulates neuronal protection against excitotoxicity in Parkinson disease. Am J Pathol 185:536–549. https://doi.org/10.1016/j.ajpath.2014.10.022
Article
CAS
PubMed
PubMed Central
Google Scholar
Holmer HK, Keyghobadi M, Moore C, Meshul CK (2005) l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 136:333–341. https://doi.org/10.1016/j.neuroscience.2005.08.003
Article
CAS
PubMed
Google Scholar
Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T, Wang ZY, Roybon L, Melki R, Li JY (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 128:805–820. https://doi.org/10.1007/s00401-014-1343-6
Article
PubMed
Google Scholar
Holmseth S, Scott HA, Real K, Lehre KP, Leergaard TB, Bjaalie JG, Danbolt NC (2009) The concentrations and distributions of three C-terminal variants of the GLT1 (EAAT2; slc1a2) glutamate transporter protein in rat brain tissue suggest differential regulation. Neuroscience 162:1055–1071. https://doi.org/10.1016/j.neuroscience.2009.03.048
Article
CAS
PubMed
Google Scholar
Hoogland ICM, Westhoff D, Engelen-Lee JY, Melief J, Valls Seron M, Houben-Weerts J, Huitinga I, van Westerloo DJ, van der Poll T, van Gool WA, van de Beek D (2018) Microglial activation after systemic stimulation with lipopolysaccharide and Escherichia coli. Front Cell Neurosci 12:110. https://doi.org/10.3389/fncel.2018.00110
Article
CAS
PubMed
PubMed Central
Google Scholar
Jain N, Bhasne K, Hemaswasthi M, Mukhopadhyay S (2013) Structural and dynamical insights into the membrane-bound alpha-synuclein. PLoS One 8:e83752. https://doi.org/10.1371/journal.pone.0083752
Article
CAS
PubMed
PubMed Central
Google Scholar
Janezic S, Threlfell S, Dodson PD, Dowie MJ, Taylor TN, Potgieter D, Parkkinen L, Senior SL, Anwar S, Ryan B, Deltheil T, Kosillo P, Cioroch M, Wagner K, Ansorge O, Bannerman DM, Bolam JP, Magill PJ, Cragg SJ, Wade-Martins R (2013) Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc Natl Acad Sci U S A 110:E4016–E4025. https://doi.org/10.1073/pnas.1309143110
Article
CAS
PubMed
PubMed Central
Google Scholar
Jankovic J (2008) Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368–376. https://doi.org/10.1136/jnnp.2007.131045
Article
CAS
PubMed
Google Scholar
Kim JM, Cha SH, Choi YR, Jou I, Joe EH, Park SM (2016) DJ-1 deficiency impairs glutamate uptake into astrocytes via the regulation of flotillin-1 and caveolin-1 expression. Sci Rep 6:28823. https://doi.org/10.1038/srep28823
Article
CAS
PubMed
PubMed Central
Google Scholar
Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH (2005) Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol 57:176–179. https://doi.org/10.1002/ana.20369
Article
CAS
PubMed
Google Scholar
Lamontagne-Proulx J, St-Amour I, Labib R, Pilon J, Denis HL, Cloutier N, Roux-Dalvai F, Vincent AT, Mason SL, Williams-Gray C, Duchez AC, Droit A, Lacroix S, Dupre N, Langlois M, Chouinard S, Panisset M, Barker RA, Boilard E, Cicchetti F (2019) Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease. Neurobiol Dis 124:163–175. https://doi.org/10.1016/j.nbd.2018.11.002
Article
CAS
PubMed
Google Scholar
Lassen LB, Gregersen E, Isager AK, Betzer C, Kofoed RH, Jensen PH (2018) ELISA method to detect alpha-synuclein oligomers in cell and animal models. PLoS One 13:e0196056. https://doi.org/10.1371/journal.pone.0196056
Article
CAS
PubMed
PubMed Central
Google Scholar
Lauderback CM, Hackett JM, Huang FF, Keller JN, Szweda LI, Markesbery WR, Butterfield DA (2001) The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J Neurochem 78:413–416. https://doi.org/10.1046/j.1471-4159.2001.00451.x
Article
CAS
PubMed
Google Scholar
Lee HJ, Suk JE, Patrick C, Bae EJ, Cho JH, Rho S, Hwang D, Masliah E, Lee SJ (2010) Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 285:9262–9272. https://doi.org/10.1074/jbc.M109.081125
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee SG, Su ZZ, Emdad L, Gupta P, Sarkar D, Borjabad A, Volsky DJ, Fisher PB (2008) Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J Biol Chem 283:13116–13123. https://doi.org/10.1074/jbc.M707697200
Article
CAS
PubMed
PubMed Central
Google Scholar
Leshchyns'ka I, Liew HT, Shepherd C, Halliday GM, Stevens CH, Ke YD, Ittner LM, Sytnyk V (2015) Abeta-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer's disease. Nat Commun 6:8836. https://doi.org/10.1038/ncomms9836
Article
CAS
PubMed
PubMed Central
Google Scholar
Lewerenz J, Maher P (2015) Chronic glutamate toxicity in neurodegenerative diseases-what is the evidence? Front Neurosci 9:469. https://doi.org/10.3389/fnins.2015.00469
Article
PubMed
PubMed Central
Google Scholar
Lin CL, Kong Q, Cuny GD, Glicksman MA (2012) Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases. Future Med Chem 4:1689–1700. https://doi.org/10.4155/fmc.12.122
Article
CAS
PubMed
PubMed Central
Google Scholar
Longhena F, Faustini G, Missale C, Pizzi M, Spano P, Bellucci A (2017) The contribution of alpha-Synuclein spreading to Parkinson's disease Synaptopathy. Neural Plast 2017:5012129. https://doi.org/10.1155/2017/5012129
Article
CAS
PubMed
PubMed Central
Google Scholar
Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP (2010) The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia 58:1094–1103. https://doi.org/10.1002/glia.20990
Article
PubMed
Google Scholar
Matsumoto J, Stewart T, Sheng L, Li N, Bullock K, Song N, Shi M, Banks WA, Zhang J (2017) Transmission of alpha-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease? Acta Neuropathol Commun 5:71. https://doi.org/10.1186/s40478-017-0470-4
Article
CAS
PubMed
PubMed Central
Google Scholar
Mitosek-Szewczyk K, Sulkowski G, Stelmasiak Z, Struzynska L (2008) Expression of glutamate transporters GLT-1 and GLAST in different regions of rat brain during the course of experimental autoimmune encephalomyelitis. Neuroscience 155:45–52. https://doi.org/10.1016/j.neuroscience.2008.05.025
Article
CAS
PubMed
Google Scholar
Morales-Prieto DM, Stojiljkovic M, Diezel C, Streicher P-E, Röstel F, Lindner J, Weis S, Schmeer C, Marz M (2018) Peripheral blood exosomes pass blood-brain-barrier and induce glial cell activation. BioRxiv. https://doi.org/10.1101/471409
Mori F, Tanji K, Yoshimoto M, Takahashi H, Wakabayashi K (2002) Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment. Exp Neurol 176:98–104. https://doi.org/10.1006/exnr.2002.7929
Article
CAS
PubMed
Google Scholar
Neildez-Nguyen TM, Wajcman H, Marden MC, Bensidhoum M, Moncollin V, Giarratana MC, Kobari L, Thierry D, Douay L (2002) Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol 20:467–472. https://doi.org/10.1038/nbt0502-467
Article
CAS
PubMed
Google Scholar
Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP (1997) Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 17:171–180
Article
CAS
Google Scholar
Norden DM, Fenn AM, Dugan A, Godbout JP (2014) TGFbeta produced by IL-10 redirected astrocytes attenuates microglial activation. Glia 62:881–895. https://doi.org/10.1002/glia.22647
Article
PubMed
PubMed Central
Google Scholar
Nwaobi SE, Cuddapah VA, Patterson KC, Randolph AC, Olsen ML (2016) The role of glial-specific Kir4.1 in normal and pathological states of the CNS. Acta Neuropathol 132:1–21. https://doi.org/10.1007/s00401-016-1553-1
Article
CAS
PubMed
PubMed Central
Google Scholar
Okumura N, Tsuji K, Nakahata T (1992) Changes in cell surface antigen expressions during proliferation and differentiation of human erythroid progenitors. Blood 80:642–650
Article
CAS
Google Scholar
Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H, Funk RH (2010) Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 5:e8762. https://doi.org/10.1371/journal.pone.0008762
Article
CAS
PubMed
PubMed Central
Google Scholar
Pan-Montojo F, Schwarz M, Winkler C, Arnhold M, O'Sullivan GA, Pal A, Said J, Marsico G, Verbavatz JM, Rodrigo-Angulo M, Gille G, Funk RH, Reichmann H (2012) Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep 2:898. https://doi.org/10.1038/srep00898
Article
CAS
PubMed
PubMed Central
Google Scholar
Papagiannakis N, Koros C, Stamelou M, Simitsi AM, Maniati M, Antonelou R, Papadimitriou D, Dermentzaki G, Moraitou M, Michelakakis H, Stefanis L (2018) Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson's disease. Neurosci Lett 672:145–149. https://doi.org/10.1016/j.neulet.2017.11.012
Article
CAS
PubMed
Google Scholar
Passmore LA, Russo CJ (2016) Specimen preparation for high-resolution Cryo-EM. Methods Enzymol 579:51–86. https://doi.org/10.1016/bs.mie.2016.04.011
Article
CAS
PubMed
PubMed Central
Google Scholar
Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M, Van den Haute C, Melki R, Baekelandt V (2015) Alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522:340–344. https://doi.org/10.1038/nature14547
Article
CAS
PubMed
Google Scholar
Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL, Zhang B, Pitkin RM, Olufemi MF, Luk KC, Trojanowski JQ, Lee VM (2018) Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies. Nature 557:558–563. https://doi.org/10.1038/s41586-018-0104-4
Article
CAS
PubMed
PubMed Central
Google Scholar
Petzold GC, Albeanu DF, Sato TF, Murthy VN (2008) Coupling of neural activity to blood flow in olfactory glomeruli is mediated by astrocytic pathways. Neuron 58:897–910. https://doi.org/10.1016/j.neuron.2008.04.029
Article
CAS
PubMed
PubMed Central
Google Scholar
Pretorius E, Swanepoel AC, Buys AV, Vermeulen N, Duim W, Kell DB (2014) Eryptosis as a marker of Parkinson's disease. Aging 6:788–819. https://doi.org/10.18632/aging.100695
Article
CAS
PubMed
PubMed Central
Google Scholar
Readnower RD, Chavko M, Adeeb S, Conroy MD, Pauly JR, McCarron RM, Sullivan PG (2010) Increase in blood-brain barrier permeability, oxidative stress, and activated microglia in a rat model of blast-induced traumatic brain injury. J Neurosci Res 88:3530–3539. https://doi.org/10.1002/jnr.22510
Article
CAS
PubMed
PubMed Central
Google Scholar
Recasens A, Dehay B (2014) Alpha-synuclein spreading in Parkinson's disease. Front Neuroanat 8:159. https://doi.org/10.3389/fnana.2014.00159
Article
PubMed
PubMed Central
Google Scholar
Rey NL, Petit GH, Bousset L, Melki R, Brundin P (2013) Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol 126:555–573. https://doi.org/10.1007/s00401-013-1160-3
Article
CAS
PubMed
PubMed Central
Google Scholar
Reynolds NP, Soragni A, Rabe M, Verdes D, Liverani E, Handschin S, Riek R, Seeger S (2011) Mechanism of membrane interaction and disruption by alpha-synuclein. J Am Chem Soc 133:19366–19375. https://doi.org/10.1021/ja2029848
Article
CAS
PubMed
Google Scholar
Rostami J, Holmqvist S, Lindstrom V, Sigvardson J, Westermark GT, Ingelsson M, Bergstrom J, Roybon L, Erlandsson A (2017) Human astrocytes transfer aggregated alpha-Synuclein via tunneling nanotubes. J Neurosci 37:11835–11853. https://doi.org/10.1523/JNEUROSCI.0983-17.2017
Article
CAS
PubMed
PubMed Central
Google Scholar
Sacino AN, Brooks M, Thomas MA, McKinney AB, Lee S, Regenhardt RW, McGarvey NH, Ayers JI, Notterpek L, Borchelt DR, Golde TE, Giasson BI (2014) Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc Natl Acad Sci U S A 111:10732–10737. https://doi.org/10.1073/pnas.1321785111
Article
CAS
PubMed
PubMed Central
Google Scholar
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676–682. https://doi.org/10.1038/nmeth.2019
Article
CAS
PubMed
Google Scholar
Sheng L, Leshchyns'ka I, Sytnyk V (2015) Neural cell adhesion molecule 2 promotes the formation of filopodia and neurite branching by inducing submembrane increases in Ca2+ levels. J Neurosci 35:1739–1752. https://doi.org/10.1523/JNEUROSCI.1714-14.2015
Article
CAS
PubMed
PubMed Central
Google Scholar
Sheng L, Leshchyns'ka I, Sytnyk V (2019) Neural cell adhesion molecule 2 (NCAM2)-induced c-Src-dependent propagation of submembrane Ca2+ spikes along dendrites inhibits synapse maturation. Cereb Cortex 29:1439–1459. https://doi.org/10.1093/cercor/bhy041
Article
PubMed
Google Scholar
Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, Yang L, Stewart T, Zheng D, Aro P, Atik A, Kerr KF, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Montine TJ, Banks WA, Zhang J (2016) CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease. Alzheimers Dement 12:1125–1131. https://doi.org/10.1016/j.jalz.2016.04.003
Article
PubMed
PubMed Central
Google Scholar
Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, Li Y, Aro P, Dator R, He C, Hipp MJ, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Banks WA, Zhang J (2014) Plasma exosomal alpha-synuclein is likely CNS-derived and increased in Parkinson's disease. Acta Neuropathol 128:639–650. https://doi.org/10.1007/s00401-014-1314-y
Article
CAS
PubMed
PubMed Central
Google Scholar
Shi M, Zabetian CP, Hancock AM, Ginghina C, Hong Z, Yearout D, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Leverenz JB, Zhang J (2010) Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. Neurosci Lett 480:78–82. https://doi.org/10.1016/j.neulet.2010.06.009
Article
CAS
PubMed
PubMed Central
Google Scholar
Shulman JM, De Jager PL, Feany MB (2011) Parkinson's disease: genetics and pathogenesis. Annu Rev Pathol 6:193–222. https://doi.org/10.1146/annurev-pathol-011110-130242
Article
CAS
PubMed
Google Scholar
Sielewicz M, Scholz J, Hanslik L (1989) A five year follow-up of 605 cases of the MCCL (metal-cancellous cementless Lubeck) total hip prosthesis. Ital J Orthop Traumatol 15:433–443
CAS
PubMed
Google Scholar
Simard M, Arcuino G, Takano T, Liu QS, Nedergaard M (2003) Signaling at the gliovascular interface. J Neurosci 23:9254–9262
Article
CAS
Google Scholar
Singh B, Covelo A, Martell-Martinez H, Nanclares C, Sherman MA, Okematti E, Meints J, Teravskis PJ, Gallardo C, Savonenko AV, Benneyworth MA, Lesne SE, Liao D, Araque A, Lee MK (2019) Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of alpha-synucleinopathy. Acta Neuropathol 138:551–574. https://doi.org/10.1007/s00401-019-02032-w
Article
CAS
PubMed
PubMed Central
Google Scholar
Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7–35. https://doi.org/10.1007/s00401-009-0619-8
Article
PubMed
Google Scholar
Sorrentino ZA, Giasson BI, Chakrabarty P (2019) Alpha-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease. Acta Neuropathol 138:1–21. https://doi.org/10.1007/s00401-019-01977-2
Article
CAS
PubMed
PubMed Central
Google Scholar
Stuendl A, Kunadt M, Kruse N, Bartels C, Moebius W, Danzer KM, Mollenhauer B, Schneider A (2016) Induction of alpha-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies. Brain 139:481–494. https://doi.org/10.1093/brain/awv346
Article
PubMed
Google Scholar
Sui YT, Bullock KM, Erickson MA, Zhang J, Banks WA (2014) Alpha synuclein is transported into and out of the brain by the blood-brain barrier. Peptides 62:197–202. https://doi.org/10.1016/j.peptides.2014.09.018
Article
CAS
PubMed
PubMed Central
Google Scholar
Suloway C, Pulokas J, Fellmann D, Cheng A, Guerra F, Quispe J, Stagg S, Potter CS, Carragher B (2005) Automated molecular microscopy: the new Leginon system. J Struct Biol 151:41–60. https://doi.org/10.1016/j.jsb.2005.03.010
Article
CAS
PubMed
Google Scholar
Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14:133–150. https://doi.org/10.1038/nrneurol.2017.188
Article
CAS
PubMed
PubMed Central
Google Scholar
Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV (2019) Blood-brain barrier: from physiology to disease and Back. Physiol Rev 99:21–78. https://doi.org/10.1152/physrev.00050.2017
Article
CAS
PubMed
Google Scholar
Teravskis PJ, Covelo A, Miller EC, Singh B, Martell-Martinez HA, Benneyworth MA, Gallardo C, Oxnard BR, Araque A, Lee MK, Liao D (2018) A53T mutant alpha-Synuclein induces tau-dependent postsynaptic impairment independently of neurodegenerative changes. J Neurosci 38:9754–9767. https://doi.org/10.1523/JNEUROSCI.0344-18.2018
Article
CAS
PubMed
PubMed Central
Google Scholar
Tian C, Liu G, Gao L, Soltys D, Pan C, Stewart T, Shi M, Xie Z, Liu N, Feng T, Zhang J (2019) Erythrocytic alpha-Synuclein as a potential biomarker for Parkinson's disease. Transl Neurodegeneration 8:15. https://doi.org/10.1186/s40035-019-0155-y
Article
CAS
Google Scholar
Tian G, Kong Q, Lai L, Ray-Chaudhury A, Lin CL (2010) Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease. J Neurochem 113:978–989. https://doi.org/10.1111/j.1471-4159.2010.06661.x
Article
CAS
PubMed
PubMed Central
Google Scholar
Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, Stoof JC, Wolters EC (1998) Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl) tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease. J Nucl Med 39:1143–1148
CAS
PubMed
Google Scholar
Turski L, Bressler K, Rettig KJ, Loschmann PA, Wachtel H (1991) Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349:414–418. https://doi.org/10.1038/349414a0
Article
CAS
PubMed
Google Scholar
Ulusoy A, Rusconi R, Perez-Revuelta BI, Musgrove RE, Helwig M, Winzen-Reichert B, Di Monte DA (2013) Caudo-rostral brain spreading of alpha-synuclein through vagal connections. EMBO Mol Med 5:1119–1127. https://doi.org/10.1002/emmm.201302475
Article
CAS
PubMed
Google Scholar
Vicente Miranda H, Cassio R, Correia-Guedes L, Gomes MA, Chegao A, Miranda E, Soares T, Coelho M, Rosa MM, Ferreira JJ, Outeiro TF (2017) Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease. Sci Rep 7:13713. https://doi.org/10.1038/s41598-017-14175-5
Article
CAS
PubMed
PubMed Central
Google Scholar
Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H (2000) NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol 99:14–20. https://doi.org/10.1007/pl00007400
Article
CAS
PubMed
Google Scholar
Wang S, Chu CH, Stewart T, Ginghina C, Wang Y, Nie H, Guo M, Wilson B, Hong JS, Zhang J (2015) Alpha-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation. Proc Natl Acad Sci U S A 112:E1926–E1935. https://doi.org/10.1073/pnas.1417883112
Article
CAS
PubMed
PubMed Central
Google Scholar
Wong YC, Krainc D (2017) Alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med 23:1–13. https://doi.org/10.1038/nm.4269
Article
CAS
PubMed
Google Scholar
Zagrean AM, Hermann DM, Opris I, Zagrean L, Popa-Wagner A (2018) Multicellular crosstalk between Exosomes and the neurovascular unit after cerebral ischemia. Therapeut Implications Front Neurosci 12:811. https://doi.org/10.3389/fnins.2018.00811
Article
Google Scholar
Zhao HQ, Li FF, Wang Z, Wang XM, Feng T (2016) A comparative study of the amount of alpha-synuclein in ischemic stroke and Parkinson's disease. Neurol Sci 37:749–754. https://doi.org/10.1007/s10072-016-2485-1
Article
PubMed
Google Scholar
Zuddas A, Oberto G, Vaglini F, Fascetti F, Fornai F, Corsini GU (1992) MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates. J Neurochem 59:733–739. https://doi.org/10.1111/j.1471-4159.1992.tb09429.x
Article
CAS
PubMed
Google Scholar